Animal studies and limited human data do not show overt developmental harm from GLP-1 exposure at typical therapeutic levels
Accordingly, rather than static policy documents or action plans, they are conceived as dynamic, continuously negotiated, and adaptable governance frameworks
One common side effect of semaglutide is itching
Animal studies show fat loss effects, but human results have been mixed
may pose choking risk in those with swallowing difficulties) Glucomannan (must be taken with sufficient water to avoid choking or oesophageal/intestinal obstruction) Inulin and other prebiotics These may indirectly support incretin secretion by slowing carbohydrate absorption, promoting beneficial gut bacteria, and stimulating L-cells in the intestine
The role of GLP-1/GIP receptor agonists in Alzheimer's disease